✦ LIBER ✦

A novel quinoline derivative, MS-209, overcomes drug resistance of human lung cancer cells expressing the multidrug resistance-associated protein (MRP) gene

✍ Scribed by Fumihiko Narasaki; Mikio Oka; Minoru Fukuda; Reiji Nakano; Koki Ikeda; Hiroshi Takatani; Kenji Terashi; Hiroshi Soda; Osamu Yano; Tsuyoshi Nakamura; L. Austin Doyle; Takashi Tsuruo; Shigeru Kohno

Publisher: Springer
Year: 1997
Tongue: English
Weight: 278 KB
Volume: 40
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s002800050681

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Expression of the multidrug resistance-a

Expression of the multidrug resistance-associated protein (MRP) and chemoresistance of human non-small-cell lung cancer cells

✍ Walter Berger; Leonilla Elbling; Erich Hauptmann; Michael Micksche 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 224 KB 👁 2 views

Human non-small-cell lung cancer (NSCLC) is considered to be a chemotherapy-refractory malignancy. The underlying mechanisms remain rather obscure. The multidrug resistanceassociated protein (MRP), mediating a multidrug resistance (MDR) phenotype, has been reported to be overexpressed in several dru

Circumvention of multidrug resistance by

Circumvention of multidrug resistance by a quinoline derivative, MS-209, in multidrug-resistant human small-cell lung cancer cells and its synergistic interaction with cyclosporin A or verapamil

✍ Punya Shrivastava; Masaki Hanibuchi; Seiji Yano; Prahlad Parajuli; Takashi Tsuru 📂 Article 📅 1998 🏛 Springer 🌐 English ⚖ 194 KB

Expression of the multidrug-resistance-a

Expression of the multidrug-resistance-associated protein (MRP) gene in human colorectal, gastric and non-small-cell lung carcinomas

✍ Yutaka Chuman; Tomoyuki Sumizawa; Yuji Takebayashi; Kiyoshi Niwa; Kazutaka Yamad 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 French ⚖ 720 KB

MRP has been identified as another multidrug-resistance (MDR) gene and may be involved in an alternative MDR mechanism in some solid tumors. We investigated the expres- sion of M R P mRNA in multidrug-resistant KB sublines (KB-8-5, KB-CZ, C -W and C A I to), human non-small-cell lung carcinomas (NSC